From Microbiome to Inflammation: The Key Drivers of Cervical Cancer.

Zhou, Zi-Wei; Long, Hui-Zhi; Cheng, Yan; Luo, Hong-Yu; Wen, Dan-Dan; Gao, Li-Chen

Zhou, Zi-Wei; Long, Hui-Zhi; Cheng, Yan; Luo, Hong-Yu; Wen, Dan-Dan; Gao, Li-Chen.

Afiliación

Zhou ZW; Department of Pharmacy, Cancer Institute, Phase I Clinical Trial Centre, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Hengyang, China.
Long HZ; Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hengyang, China.
Cheng Y; Department of Pharmacy, Cancer Institute, Phase I Clinical Trial Centre, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Hengyang, China.
Luo HY; Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hengyang, China.
Wen DD; Department of Pharmacy, Cancer Institute, Phase I Clinical Trial Centre, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Hengyang, China.
Gao LC; Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research, Hengyang, China.

Front Microbiol ; 12: 767931, 2021.

Article en En | MEDLINE | ID: mdl-34867901

Palabras clave

cervical cancer; immunotherapy; inflammation; microbiome; probiotic

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Microbiol Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google